Talinolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263127This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H33N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3S82268BKG, chemically known as urea, n-cyclohexyl-n-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)- but generally known as talinolol, which bears US NIH Compound Identifier 68770. European Medicines Agency schedules Talinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10804MIG. The term TALINOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules talinolol in its Anatomical Therapeutic Chemical (ATC) Classification. TALINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule talinolol under HS 29242190 and SITC 51473. As of Q4 2014, TALINOLOL remains the US FDA Preferred Term for this commodity. Talinolol bears US NLM identifiers UMLS ID C0075783 and NCI Concept Code C73020. SMILES: O=C(NC1CCCCC1)NC1CCC(OCC(O)CNC(C)(C)C)CC1.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.